Streetbeat News

Earnings

PAA

Plains All American Pipeline (PAA) has raised its FY24 Adjusted EBITDA outlook by $75 million to a new range of $2.725 billion to $2.775 billion. The company also reiterated its full-year 2024 Adjusted Free Cash Flow guidance of $1.55 billion.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:37 am

TWST

Twist Bioscience has updated its Q4 2024 revenue guidance to $82M-$83M, surpassing both its prior guidance of $77M-$80M and the consensus estimate of $79.602M. The company also expects a gross margin of approximately 44% and an adjusted EBITDA loss of $20 million.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:37 am

RMD

ResMed shares are trading lower following the company's Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:37 am

USM

United States Cellular (NYSE:USM) reported Q2 earnings per share of $0.20, beating the analyst estimate of $0.14 by 42.86%. Sales were $927 million, slightly above the $925.08 million estimate. Despite the earnings beat, sales decreased by 3.13% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:36 am

OLED

Universal Display shares are trading lower following worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:35 am

PAGP

Plains GP Holdings (NASDAQ:PAGP) reported Q2 2024 earnings per share (EPS) of $0.20, missing the analyst consensus estimate of $0.31 by 35.48%. However, the company reported sales of $12.930 billion, beating the estimate of $12.409 billion by 4.20%. Compared to the same period last year, EPS decreased by 20%, while sales increased by 11.47%.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:35 am

AMD

INTC

NVDA

TSM

Intel shares plummeted 21% in pre-market trading following disappointing Q2 results, a 15% workforce reduction, and dividend suspension. This marks Intel's worst drop since 2000, potentially losing $25 billion in market value. The company struggles to compete with TSMC, Nvidia, and AMD.

Portfolio Pulse from Benzinga Neuro

August 02, 2024 | 11:35 am

MCHP

Microchip Technology shares are trading lower after the company reported mixed Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:35 am

TWST

Twist Bioscience has updated its financial guidance for fiscal year 2024, expecting total revenue of $310M-$311M, up from prior guidance of $300M-$304M and above the consensus of $303.906M. The company anticipates growth in SynBio and NGS revenues, while Biopharma revenue is expected to decline. Gross margin is projected at the high end of previous guidance, and loss from operations is slightly improved. Capital expenditure is reduced, and ending cash is expected to be higher than previously forecasted.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:35 am

CBOE

Cboe Global Markets has updated its fiscal year 2024 guidance, expecting net revenue growth of 6%-8%, up from the previous 5%-7%. The company reaffirmed its adjusted operating expenses, depreciation and amortization expenses, minority investment contributions, effective tax rate, and capital expenditures.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:34 am